Log in to save to my catalogue

Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide?...

Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide?...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1790953174

Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study

About this item

Full title

Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study

Publisher

New York: Springer US

Journal title

Journal of neuro-oncology, 2016-05, Vol.128 (1), p.157-162

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

The role of temozolomide concurrent with and adjuvant to radiotherapy (RT/TMZ) in elderly patients with glioblastoma (GBM) remains unclear. We evaluated the outcome of patients >70 years in the context of the Project of Emilia-Romagna Region in Neuro-Oncology (PERNO), the first Italian prospective observational population-based study in neuro-oncol...

Alternative Titles

Full title

Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1790953174

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1790953174

Other Identifiers

ISSN

0167-594X

E-ISSN

1573-7373

DOI

10.1007/s11060-016-2093-1

How to access this item